Jun 5, 2023

Improving prostate cancer screening: accounting for genetic determinants of PSA variation

Posted by in categories: biotech/medical, genetics

In a recent study published in Nature Medicine, researchers conducted a genome-wide analysis of prostate-specific antigen (PSA) levels of men without prostate cancer to understand the non-cancer-related variation in PSA levels to improve decision-making during the diagnosis of prostate cancer.

Study: Genetically adjusted PSA levels for prostate cancer screening. Image Credit: luchschenF/Shutterstock.com.

Leave a reply